DOI:
10.1055/s-00000072
Seminars in Reproductive Medicine
LinksClose Window
References
Abbara A, Clarke S, Islam R. , et al.
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.
Hum Reprod 2017;
32 (09) 1915-1924
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.